Selamectin (Revolution)

Selamectin is a macrocyclic lactone anthelmintic medication that provides comprehensive parasite protection through convenient topical application. Marketed under the brand name Revolution for dogs, selamectin offers broad-spectrum activity against multiple parasites including heartworms, fleas, ear mites, sarcoptic mange mites, and certain ticks. This multi-parasite coverage makes selamectin an attractive option for dogs requiring protection against several external and internal parasites with a single monthly application. The topical formulation provides an alternative to oral medications for dogs that are difficult to pill or for owners who prefer not to use oral preventatives.

The mechanism of action of selamectin involves binding to glutamate-gated chloride channels in parasite nerve and muscle cells, similar to other macrocyclic lactones. This binding causes increased permeability to chloride ions, resulting in hyperpolarization, paralysis, and death of susceptible parasites. When applied topically to dogs, selamectin is absorbed through the skin and distributed systemically, reaching concentrations effective against heartworm larvae transmitted by mosquitoes and other target parasites. The unique distribution properties of selamectin allow it to concentrate in sebaceous glands and redistribute onto the skin and hair coat, providing activity against external parasites while also achieving systemic levels effective against internal parasites.

Revolution is available as a ready-to-use topical solution in single-dose applicator tubes designed for easy monthly application. The product comes in multiple concentration strengths corresponding to different dog weight ranges, ensuring appropriate dosing from small breeds to large breeds. The solution is applied directly to the skin at the base of the neck, where the dog cannot easily lick it off during the drying period. Most dogs tolerate the application process well, and once dry, the product provides protection for approximately one month. Revolution Plus, a newer formulation, combines selamectin with sarolaner to provide enhanced tick protection while maintaining the established heartworm and flea efficacy.

The safety profile of selamectin in dogs has been well-established through extensive clinical trials and many years of commercial use. The medication has demonstrated consistent safety across diverse patient populations when used according to label directions. As with all macrocyclic lactones, dogs with the MDR1 gene mutation may theoretically have increased sensitivity to selamectin, though clinical evidence suggests that selamectin may have a wider safety margin than some other drugs in this class for affected breeds. Nevertheless, veterinary guidance remains important for all dogs, and those with known MDR1 status or breeds at risk for the mutation should be evaluated appropriately before starting any heartworm preventative.

The primary indication for selamectin in dogs is the prevention of heartworm disease caused by Dirofilaria immitis. When applied monthly, selamectin eliminates heartworm larvae transmitted through mosquito bites before they can develop into adult worms that reside in the heart and pulmonary vessels. Heartworm disease remains a significant health threat to dogs, with infection potentially causing progressive cardiovascular damage, respiratory compromise, and death if left untreated. Regular monthly application of selamectin provides reliable protection against this serious parasitic disease, making it an integral component of comprehensive preventive care for dogs in heartworm-endemic areas.

Beyond heartworm prevention, selamectin provides excellent flea control that makes Revolution a versatile choice for dogs requiring both internal and external parasite protection. Selamectin kills adult fleas and prevents flea eggs from hatching, helping to control flea populations in the environment as well as on the treated dog. This dual action disrupts the flea lifecycle at multiple points, making Revolution effective for managing flea infestations and preventing reinfestation. For dogs with flea allergy dermatitis, consistent monthly selamectin application can significantly reduce allergic symptoms by maintaining flea-free status.

Selamectin is also indicated for the treatment and control of ear mites (Otodectes cynotis) in dogs. Ear mites are common parasites that cause intense itching, head shaking, and ear infections in affected dogs. Traditional ear mite treatments require application directly into the ear canal, often multiple times over several weeks. Selamectin provides convenient whole-body treatment when applied to the skin at the back of the neck, eliminating the need for ear manipulation that can be distressing for some dogs. A single application is typically effective for ear mite treatment, though follow-up may be needed in severe or persistent cases.

Sarcoptic mange, caused by the mite Sarcoptes scabiei, responds well to selamectin treatment. This highly contagious mite causes intense itching, hair loss, and skin irritation in dogs and can potentially spread to humans and other animals. Revolution provides an effective treatment option for sarcoptic mange when applied according to label directions, typically requiring multiple monthly applications to fully resolve the infestation. The ease of topical application compared to some alternative treatments makes selamectin a practical choice for managing this uncomfortable condition.

Revolution Plus, which combines selamectin with sarolaner, expands the tick protection offered by the original Revolution formulation. The combination product is indicated for the treatment and control of American dog tick (Dermacentor variabilis), black-legged tick (Ixodes scapularis), and Gulf Coast tick (Amblyomma maculatum) infestations. This enhanced tick coverage is particularly valuable in regions where tick-borne diseases are prevalent. The addition of sarolaner also provides broader flea killing activity, complementing selamectin's flea prevention effects. Veterinarians often recommend Revolution Plus for dogs requiring comprehensive ectoparasite protection alongside heartworm prevention.

Selamectin dosing follows a weight-based protocol with topical application to ensure effective parasite protection across the range of dog sizes. The recommended minimum dose for heartworm prevention and flea control is 6 milligrams of selamectin per kilogram of body weight, applied topically once monthly. Revolution products are available in several package sizes corresponding to different weight ranges, making selection straightforward once your dog's weight is accurately determined. Your veterinarian will recommend the appropriate product size based on your dog's current body weight, and the dose should be reassessed if significant weight changes occur.

Commercial Revolution products are packaged with specific weight ranges clearly indicated. Products are typically available for dogs weighing up to 5 pounds, 5.1 to 10 pounds, 10.1 to 20 pounds, 20.1 to 40 pounds, 40.1 to 85 pounds, and 85.1 to 130 pounds. Revolution Plus follows similar weight-based packaging. Dogs exceeding the largest single-tube weight range may require combinations of tubes as directed by a veterinarian. Accurate weight measurement is important, as underdosing may result in inadequate protection while significantly overdosing, though generally well-tolerated, should be avoided. Growing puppies should have their weight checked regularly to ensure they receive the appropriate product as they mature.

Heartworm prevention requires consistent monthly application throughout the year in most regions. The monthly interval is based on the time required for transmitted heartworm larvae to develop to a stage vulnerable to selamectin, and maintaining this schedule ensures continuous protection without gaps. Even in areas with seasonal mosquito activity, year-round prevention is often recommended to eliminate risk from unseasonable mosquito activity and to maintain continuous flea control. Setting a monthly reminder helps ensure applications are not missed, as gaps in coverage could allow heartworm infection to become established.

Proper application technique is essential for selamectin to provide effective protection. Part the fur at the base of the neck in front of the shoulder blades to expose the skin. Apply the entire contents of the applicator tube directly onto the skin at a single spot. Avoid applying to wet or broken skin. Do not massage the product into the skin; simply allow it to dry naturally. The application site should remain undisturbed while drying, and dogs should be prevented from licking the site or grooming other treated animals until the product has dried completely, typically within a few hours. Bathing or swimming should be avoided for at least two hours after application, though once dry, normal bathing and water exposure do not significantly affect efficacy.

If a monthly dose is missed, apply selamectin as soon as you remember and then resume the regular monthly schedule. If several doses have been missed, consult your veterinarian, as heartworm testing may be recommended before resuming prevention to ensure your dog has not become infected during the gap in coverage. Do not apply multiple doses at once to make up for missed applications. For optimal protection, administering selamectin on the same day each month helps establish a routine that minimizes the risk of forgotten doses.

Before starting selamectin heartworm prevention and annually thereafter, dogs should be tested for existing heartworm infection. Administering preventative medication to dogs already infected with adult heartworms can potentially cause adverse reactions and will not eliminate the existing adult worm infection. Puppies can begin selamectin treatment as early as six weeks of age, though the timing of initial heartworm testing depends on when prevention was started. Maintaining regular veterinary visits and heartworm testing ensures early detection if infection occurs despite preventive treatment and confirms that your prevention program is working effectively.

Selamectin demonstrates an excellent safety profile in dogs, with most animals showing no adverse effects when the medication is applied according to label directions. Clinical trials during product development and years of post-market experience have confirmed that Revolution is well-tolerated across diverse canine populations. The topical route of administration avoids gastrointestinal passage of the medication, which may reduce the likelihood of digestive side effects compared to oral preventatives in some dogs. However, as with any medication, some dogs may experience adverse reactions, and owner awareness allows for prompt recognition and appropriate response.

The most commonly observed adverse effects with selamectin are localized reactions at the application site. Some dogs may show temporary hair loss, hair discoloration, or clumping of fur at the site where the product was applied. Mild skin irritation, redness, or itching at the application site has been reported in some animals and typically resolves without treatment within a few days. These local reactions are generally cosmetic or mildly uncomfortable rather than medically significant. If significant skin irritation develops or persists, bathing the area with mild soap and water and consulting your veterinarian is advisable.

Systemic side effects are uncommon with selamectin at recommended doses but may occur in some dogs. Digestive disturbances including vomiting, diarrhea, or decreased appetite have been reported occasionally. Some dogs may show temporary lethargy or changes in activity level following application. Drooling has been noted in some cases, particularly if dogs manage to lick the application site before it has fully dried. Muscle tremors or incoordination are rare but have been reported. These systemic effects, when they occur, are typically mild and self-limiting, resolving within a day or two without specific treatment.

More serious adverse reactions to selamectin are rare in dogs without specific sensitivities. Signs of a severe allergic reaction may include significant facial swelling, difficulty breathing, widespread hives, or collapse and require immediate emergency veterinary care. Neurological symptoms including severe ataxia, blindness, tremors, or seizures are uncommon but should prompt immediate veterinary attention if observed. If your dog ingests a significant amount of selamectin by licking the application site before it dries, contact your veterinarian or an animal poison control center for guidance.

Dogs with the MDR1 gene mutation may have increased sensitivity to selamectin and other macrocyclic lactones. However, evidence suggests that selamectin may have a wider safety margin in MDR1-affected dogs compared to some other drugs in this class, possibly due to its unique chemical structure and pharmacokinetic properties. Clinical reports of selamectin toxicity in MDR1 dogs are less common than with ivermectin at comparable doses. Nevertheless, dogs of breeds at risk for the MDR1 mutation, including Collies, Australian Shepherds, Shetland Sheepdogs, and related breeds, should be monitored appropriately following selamectin application. Genetic testing provides valuable information about mutation status and helps inform heartworm prevention choices for at-risk breeds.

Selamectin is contraindicated in dogs with known hypersensitivity to selamectin or other macrocyclic lactone compounds. Dogs that have experienced allergic reactions or significant adverse effects following administration of any macrocyclic lactone medication, including ivermectin, milbemycin, or moxidectin, should be carefully evaluated before receiving selamectin. A history of severe reactions to related drugs may indicate increased risk with selamectin, though the specific reaction pattern and individual circumstances should be discussed with your veterinarian to determine the safest heartworm prevention approach.

Dogs with existing heartworm infection should not begin selamectin or any heartworm preventative without appropriate veterinary evaluation and management of their infection. Administering preventative medications to dogs infected with adult heartworms does not eliminate the adult worms and may potentially cause adverse reactions, particularly in dogs with circulating microfilariae. All dogs must be tested for heartworm infection before starting preventive therapy, and positive dogs require appropriate treatment for their infection under veterinary supervision. Annual heartworm testing is recommended for dogs on prevention to detect any breakthrough infections early.

Selamectin is labeled for use in dogs six weeks of age and older. Puppies younger than six weeks should not receive Revolution, as the safety in very young animals has not been established. Additionally, dogs must meet minimum weight requirements specified on product labeling before treatment. Very debilitated, sick, or underweight dogs should be evaluated by a veterinarian to determine if selamectin is appropriate, as these animals may handle medications differently than healthy dogs. If your dog has recently been ill or undergone surgery, consult your veterinarian about timing of selamectin application.

The MDR1 gene mutation warrants consideration when selecting heartworm prevention for at-risk breeds, though selamectin may be better tolerated than some alternatives in affected dogs. Breeds with high prevalence of the MDR1 mutation include Collies, Australian Shepherds, Shetland Sheepdogs, Old English Sheepdogs, Border Collies, German Shepherds, and mixed breeds with herding heritage. While clinical experience and some pharmacological evidence suggest that selamectin has a relatively favorable safety profile in MDR1 dogs compared to some other macrocyclic lactones, individual sensitivity can vary. Genetic testing provides definitive information about mutation status and can help guide prevention choices in consultation with your veterinarian.

Application site considerations may affect selamectin suitability in some dogs. Revolution should not be applied to wet or broken skin, as this may alter absorption and increase the risk of local reactions. Dogs with severe skin conditions affecting the application area may need those conditions managed before starting topical prevention. If your dog has open wounds, surgical incisions, or significant dermatological disease at the back of the neck, discuss alternative application sites or timing with your veterinarian. Dogs that excessively groom themselves or are groomed by other pets in the household may not be ideal candidates for topical preventatives if the product cannot remain in place while drying.

Understanding potential drug interactions helps ensure safe use of selamectin in dogs receiving other medications. As a macrocyclic lactone, selamectin is a substrate for P-glycoprotein, the transport protein that plays important roles in drug distribution and elimination. Medications that affect P-glycoprotein function can theoretically alter selamectin levels in the body, though clinically significant interactions appear to be less common with selamectin than with some other drugs in this class. Full disclosure of all medications, supplements, and over-the-counter products your dog receives allows your veterinarian to assess potential interactions.

Some drug classes have been identified as potential interactors with macrocyclic lactones generally, though specific data on selamectin interactions may be limited. Spinosad, used in some oral flea control products, has been associated with elevated ivermectin levels when used concurrently, and theoretical concerns exist for other macrocyclic lactones. However, Revolution provides its own flea control, so concurrent use of spinosad flea products would typically be unnecessary. If your dog requires specific flea treatment products in addition to Revolution for any reason, discuss potential interactions with your veterinarian. P-glycoprotein inhibitors including some azole antifungal medications and cyclosporine could theoretically affect selamectin pharmacokinetics.

The topical administration route of selamectin avoids direct gastrointestinal absorption, which may reduce some drug interaction potential compared to oral medications. Food-drug interactions are not relevant since the medication is not taken orally. However, once absorbed through the skin, selamectin enters systemic circulation and could potentially interact with other medications at the level of distribution, metabolism, or elimination. When dogs receive multiple medications, your veterinarian considers the overall drug profile to identify and manage potential interactions.

Supplements commonly given to dogs, including joint supplements, omega fatty acids, and probiotics, are not known to significantly interact with topically applied selamectin. Herbal supplements may have unpredictable effects on drug metabolism, and complete disclosure of all supplements to your veterinarian is advisable. Some owners use multiple parasite control products concurrently, and while this is sometimes appropriate, it should be done under veterinary guidance to avoid duplication of drug classes or unintended interactions.

Communication with your veterinarian about your dog's complete medication regimen supports safe selamectin use. Before starting any new medication while your dog is receiving Revolution, ensure the prescribing veterinarian is aware of your dog's heartworm preventative. Similarly, when choosing Revolution, inform your veterinarian of all current medications. Watch for any changes in your dog's health or behavior following introduction of new medications, as this could potentially indicate an interaction. Dogs receiving multiple medications may benefit from periodic reassessment of their complete drug profile during routine veterinary visits.

Proper application technique is essential for selamectin to provide effective parasite protection. The product must be applied directly to the skin, not just onto the hair coat, to ensure adequate absorption. Part the fur to expose the skin at the base of the neck, and apply the full contents of the applicator tube to a single spot. Avoid application to areas where the dog can reach to lick, as oral ingestion can cause adverse effects and reduces the available dose for systemic distribution. Prevent treated dogs from grooming each other until the application site has dried completely, which typically takes several hours.

The MDR1 gene mutation remains a consideration for selamectin use, though evidence suggests this medication may be better tolerated in affected dogs than some other macrocyclic lactones. Dogs carrying this mutation have impaired ability to exclude certain drugs from the central nervous system, potentially resulting in neurological effects. Breeds commonly affected include Collies, Australian Shepherds, Shetland Sheepdogs, Border Collies, Old English Sheepdogs, and related breeds. Mixed breed dogs with herding heritage should also be considered potentially at risk. While clinical reports of selamectin toxicity in MDR1 dogs are less common than with some other drugs in this class, monitoring for any adverse effects following application remains prudent. Genetic testing provides definitive information about mutation status.

Environmental and household considerations apply when using topical selamectin. The product is alcohol-based and flammable until dry, so treated dogs should be kept away from open flames or sparks until the application site has completely dried. Children and other pets should avoid contact with the application site until dry to prevent inadvertent transfer or ingestion. In multi-pet households, separating animals until the product has dried prevents pets from grooming each other and potentially ingesting the medication. The dried product does not transfer significantly to bedding or furniture under normal circumstances.

Monitoring your dog following selamectin application helps ensure any adverse effects are recognized promptly. Observe the application site for signs of irritation, and watch your dog for any systemic effects including lethargy, digestive upset, or neurological changes. Most dogs show no adverse effects whatsoever, but awareness enables prompt response if problems occur. If you notice significant skin reactions, persistent symptoms, or any concerning changes in your dog's behavior or health, contact your veterinarian. Keeping records of application dates helps maintain the monthly schedule and provides useful information for your veterinarian.

Special populations require additional consideration when using selamectin. Puppies must be at least six weeks of age before treatment. Senior dogs should have their overall health assessed as part of routine veterinary care, as age-related changes may affect medication tolerance. Dogs with liver or kidney disease may process medications differently and warrant veterinary evaluation. The safety of selamectin in breeding dogs has been evaluated, with studies showing no adverse effects on breeding performance or offspring when used according to label directions. However, pregnant or lactating dogs should have any medication use reviewed with their veterinarian. Working dogs should be monitored for any effects on performance following application.

Proper storage of selamectin topical products maintains medication stability and effectiveness throughout the product's shelf life. Revolution should be stored at controlled room temperature, typically between 59 and 86 degrees Fahrenheit (15 to 30 degrees Celsius). Avoid exposing the product to extreme temperatures, whether excessive heat or freezing conditions, as these can affect the formulation. Do not store in vehicles during hot or cold weather, and keep away from direct sunlight and heat sources. The individual applicator tubes provide protection from light and environmental factors until opened.

Keep Revolution in its original packaging until ready for use. The packaging is designed to protect the product from light and environmental exposure that could degrade the active ingredients. Check expiration dates before application and do not use products that have passed their expiration date. Expired medications may have reduced effectiveness against parasites. Most pet owners purchase Revolution in multi-month supplies, so rotating through packages chronologically ensures products are used before expiration. Setting monthly reminders for application helps establish a routine that also serves as a reminder to check supplies.

Safe handling of selamectin products protects both pets and humans in the household. Store Revolution out of reach of children and pets, as the individual tubes could be attractive to animals and the contents could cause harm if ingested. While selamectin in Revolution is formulated specifically for topical use in pets, human exposure should be avoided. Wash hands thoroughly after handling the product and applying it to your dog. Avoid contact with eyes, and if accidental exposure occurs, rinse thoroughly with water. People who are sensitive to macrocyclic lactones or who have skin conditions should use extra caution when handling the product or consider having another household member perform applications.

Disposal of used applicators and expired products should follow local guidelines for pharmaceutical waste. Empty applicator tubes can typically be disposed of in regular household trash. Unused or expired medication should not be flushed down drains or toilets. Many communities offer pharmaceutical take-back programs that provide environmentally responsible disposal options. Alternatively, mix unused medication with undesirable substances and place in a sealed container before disposal in household trash. Remove or obscure any personal information from packaging before disposal.

Selamectin topical products are generally appropriate for dogs of all breeds when used according to label directions, though certain breed-specific factors warrant consideration. As with all macrocyclic lactone medications, the MDR1 gene mutation represents the primary breed-related concern, affecting drug distribution and potentially increasing sensitivity in affected dogs. Understanding your dog's genetic status or breed background helps inform heartworm prevention choices and appropriate monitoring during treatment.

Breeds with documented prevalence of the MDR1 mutation include Collies (approximately 70% affected), Australian Shepherds (approximately 50% affected), Shetland Sheepdogs, Old English Sheepdogs, Border Collies, English Shepherds, German Shepherds, Long-haired Whippets, and Silken Windhounds. Mixed breed dogs with any herding breed heritage should also be considered potentially at risk, as the mutation can be present even when herding ancestry is not obvious. Genetic testing provides definitive information about MDR1 status through simple cheek swabs or blood samples available from veterinary clinics and commercial laboratories.

Selamectin may have a more favorable safety profile in MDR1-affected dogs compared to some other macrocyclic lactones, based on its chemical structure and pharmacokinetic properties. Clinical reports of selamectin toxicity in MDR1 dogs appear less common than with ivermectin at comparable doses. However, individual sensitivity can vary, and dogs with the MDR1 mutation still represent a population with potential increased risk. For dogs known to be homozygous for the mutation, careful monitoring following selamectin application is advisable, and some veterinarians may recommend alternative preventatives based on individual circumstances.

Size and coat considerations affect practical application of topical selamectin across different breeds. Small and toy breeds require accurate weight assessment to ensure appropriate dosing, as the products are weight-specific and underdosing could result in inadequate protection. Giant breeds may require multiple applicators or specific large-breed products. Breeds with very dense or double coats may require careful parting of the fur to ensure the product reaches the skin rather than remaining on the hair. Breeds that are bathed or swim frequently should have applications timed appropriately, allowing the product to dry completely before water exposure. Age considerations apply across all breeds, with puppies needing to meet minimum age requirements before starting prevention and senior dogs benefiting from regular health monitoring as part of their overall care.

Several alternative heartworm preventatives offer options for dogs that may benefit from different active ingredients, formulations, or routes of administration. Oral macrocyclic lactones including ivermectin (Heartgard) and milbemycin oxime (Interceptor) provide effective monthly heartworm prevention through chewable tablet formulations. Moxidectin (ProHeart) offers extended-duration injectable prevention lasting six or twelve months. Each alternative has specific characteristics that may make it more or less suitable for individual dogs based on factors including breed sensitivities, owner preferences, and concurrent parasite protection needs.

Within the topical heartworm prevention category, Revolution Plus represents an enhanced formulation combining selamectin with sarolaner. The addition of sarolaner provides improved tick control compared to original Revolution, addressing American dog ticks, black-legged ticks, and Gulf Coast ticks while maintaining the heartworm, flea, and other parasite protection of the original product. For dogs in tick-endemic areas requiring comprehensive ectoparasite protection alongside heartworm prevention, Revolution Plus may offer advantages over the original selamectin-only formulation. Other topical combination products address different parasite spectra and may be considered based on regional parasite prevalence.

Complementary therapies and integrated approaches support comprehensive parasite protection for dogs receiving selamectin. While Revolution provides heartworm prevention, flea control, and activity against ear mites and sarcoptic mange, dogs may require additional protection against other parasites depending on their geographic location and lifestyle. Intestinal parasite control may require separate deworming products, as selamectin does not provide comprehensive coverage against common gastrointestinal worms. Tick protection beyond what Revolution Plus provides may be needed in heavily endemic areas. Environmental management including flea treatment of the home and yard complements on-animal flea control. Always consult with your veterinarian before combining parasite control products or changing your dog's heartworm prevention protocol, as maintaining continuous, appropriate protection is essential for your dog's health.